SEC Form 5 · accession 0001209191-16-103782
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Dec 31, 2015
Accepted (ET)
Mar 1, 2016 · 2:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 24, 2015 | G | 7,188,061 | $0.00 | D | 0 | I | Through Cambridge Equities, LP |
| Common StockF1,F3 | Jul 24, 2015 | G | 7,188,061 | $0.00 | A | 7,188,061 | I | Through The Chan Soon-Shiong Family Foundation |
| Common Stock | holding | — | — | — | 873,938 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $5.80 | holding | — | — | — | Dec 22, 2014 | Dec 22, 2017 | Common Stock | 1,724,138 | 1,724,138 | I |
Explanation of responses
- F1On July 24, 2015, Cambridge Equities, LP ("Cambridge Equities") donated 7,188,061 of the common stock of Sorrento Therapeutics, Inc. ("Sorrento") to The Chan Soon-Shiong Family Foundation ("CSFF"), a non-profit organization.
- F2Dr. Patrick Soon-Shiong is the sole member of MP 13 Ventures, LLC, which is the general partner of Cambridge Equities.
- F3Dr. Patrick Soon Shiong is the Chairman of CSFF.
Remarks
This Form 5 shall not be deemed to be an admission by any reporting person hereunder that it or he is the beneficial owner, for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), for purposes of Section 13 of the Exchange Act, or for any other purpose, of any of the securities reported herein. Without limiting the immediately preceding sentence, each reporting person hereunder expressly disclaims beneficial ownership, for purposes of Section 16 of the Exchange Act, of all securities reported herein, except to the extent of its or his pecuniary interest therein.